Marc Miravitlles spends much of his time researching COPD, Internal medicine, Physical therapy, Intensive care medicine and Exacerbation. The study incorporates disciplines such as Pulmonary disease, Quality of life, Disease, Severity of illness and Spirometry in addition to COPD. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Sputum, Surgery and Pathology.
His Physical therapy research incorporates elements of Cross-sectional study, Respiratory disease, Obstructive lung disease and Quality of life. He has included themes like Chronic bronchitis, Asthma, Cohort and Emergency medicine in his Intensive care medicine study. His Exacerbation study combines topics in areas such as Ambulatory and Salmeterol.
COPD, Internal medicine, Intensive care medicine, Physical therapy and Pulmonary disease are his primary areas of study. His COPD study combines topics from a wide range of disciplines, such as Exacerbation, Quality of life, Asthma, Disease and Pediatrics. His work on Chronic bronchitis, Observational study and Spirometry as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
His biological study spans a wide range of topics, including Moxifloxacin and Bronchitis. His Intensive care medicine study integrates concerns from other disciplines, such as Antibiotics and Clinical trial. The study incorporates disciplines such as Severity of illness and Epidemiology in addition to Physical therapy.
His scientific interests lie mostly in COPD, Internal medicine, Intensive care medicine, Pulmonary disease and Exacerbation. His study in the field of Obstructive lung disease also crosses realms of In patient. His studies link Gastroenterology with Internal medicine.
His research in Intensive care medicine intersects with topics in Clinical trial, Bronchiectasis, Quality of life, Guideline and Inhaled corticosteroids. His work deals with themes such as Body mass index, Multivariate analysis, Emergency medicine, Hazard ratio and Bronchodilator, which intersect with Exacerbation. The concepts of his Asthma study are interwoven with issues in Eosinophilia, Chronic bronchitis and Asthma copd overlap.
His primary scientific interests are in COPD, Internal medicine, Intensive care medicine, Pulmonary disease and Exacerbation. His COPD research integrates issues from Spirometry, Asthma, Eosinophilia and Disease. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Alpha and Genetic data.
His Intensive care medicine research is multidisciplinary, relying on both Inhaled corticosteroids, Clinical research, Guideline and Quality of life. His Pulmonary disease research is multidisciplinary, incorporating elements of Respiratory Medicine, Mechanical ventilation, Primary care, Pulmonary function testing and Interstitial lung disease. His Exacerbation research is multidisciplinary, incorporating perspectives in Likert scale, Predictive value, Mean age and Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Chronic obstructive pulmonary disease
Marc Decramer;Wim Janssens;Marc Miravitlles.
The Lancet (2012)
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.
Victor Sobradillo Peña;Marc Miravitlles;Rafael Gabriel;Carlos A. Jiménez-Ruiz.
Epidemiology and costs of chronic obstructive pulmonary disease.
K R Chapman;D M Mannino;J B Soriano;P A Vermeire.
European Respiratory Journal (2006)
Outcomes for COPD pharmacological trials: From lung function to biomarkers
M. Cazzola;W. MacNee;F.J. Martinez;K.F. Rabe.
European Respiratory Journal (2008)
Prevalence of copd in spain: impact of undiagnosed copd on quality of life and daily life activities.
Marc Miravitlles;Joan B Soriano;Francisco Garcia-Rio;Luis Muñoz.
Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
V Brusasco;R Hodder;M Miravitlles;L Korducki.
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study
M Miravitlles;M Ferrer;À Pont;R Zalacain.
Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD
Marc Miravitlles;Cristina Espinosa;Enrique Fernández-Laso;José Alberto Martos.
Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
Tobias Welte;Marc Miravitlles;Paul Hernandez;Göran Eriksson.
American Journal of Respiratory and Critical Care Medicine (2009)
Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients : A multiple logistic regression analysis
Marc Miravitlles;Tina Guerrero;Cristina Mayordomo;Leopoldo Sánchez-Agudo.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: